Abstract

The inflammatory response in pediatric sepsis is highly dynamic and includes both pro- and anti-inflammatory elements that involve the innate and adaptive immune systems. While the pro-inflammatory response is responsible for the initial clinical signs and symptoms of sepsis, a concurrent compensatory anti-inflammatory response often results in an occult, but highly clinically relevant, form of acquired immunodeficiency. When severe, this is termed “immunoparalysis” and is associated with increased risks for nosocomial infection, prolonged organ dysfunction, and death. This review focuses on the pathophysiology and clinical implications of both over- and under-active immune function in septic children. Host-, disease-, and treatment-specific risk factors for immunoparalysis are reviewed along with immune phenotype-specific approaches for immunomodulation in pediatric sepsis which are currently the subject of clinical trials.

Highlights

  • Sepsis represents a dysregulated host response to infection that, when severe, results in organ dysfunction

  • The pathophysiology of the immune response in sepsis is an attractive target for the development of novel treatments to improve outcomes in critically ill children with sepsis

  • Sepsis is triggered by an initial infectious insult, much of the damage done to the host is not directly due to the pathogen but to the dysregulated host inflammatory response that can persist even after the initial infection has been controlled

Read more

Summary

Introduction

Sepsis represents a dysregulated host response to infection that, when severe, results in organ dysfunction. While the timely recognition of sepsis and provision of fluid resuscitation and antibiotics have resulted in improvements in sepsis outcomes over the last two decades [3,4], over 7000 children still die of sepsis every year in the United States alone [5]. The pathophysiology of the immune response in sepsis is an attractive target for the development of novel treatments to improve outcomes in critically ill children with sepsis. We know that the immune response in sepsis is highly dynamic, with many children demonstrating a compensatory anti-inflammatory response that represents a clinically important, occult form of acquired immune deficiency. Understanding the variability of the immune response in children with sepsis will allow the development of new, personalized approaches to sepsis treatment

Innate and Adaptive Immune Systems
Immunoparalysis
Gene Expression
Immunothrombosis
Developmental Effects on Immune Response
Infection Specific
Treatment Specific
Current Research and Future Directions
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call